HNF4A and gastric cancer: ITLN1 treatment reduced the proliferation and the migratory ability of gastric cancer cells by upregulating hepatocyte nuclear factor 4α (HNF4a) via increased inhibition of nuclear factor kappa B (NFkB) (46).